
  <style>
  .gh-table table { 
    border-collapse: collapse; 
    width: 100%;
    border: 1px solid #444;
    font-size: 12px;
  }
  .gh-table th, .gh-table td { 
    border: 1px solid #444; 
    padding: 4px 6px; 
    vertical-align: top;
    font-weight: 400 !important;   /* regular font */
  }
  .gh-table th { 
    .gh-table th { background: #f5f5f5; text-align: left; }
  }
  .gh-table th { font-weight: 700 !important; }
    @media print {
      .gh-table { font-size: 10px; }
    }
  </style>
  <div class='gh-table'><table><thead><tr><th>Molecola (1)</th><th>Molecola (2)</th><th>description</th></tr></thead><tbody><tr><td>Cobicistat</td><td>Fenofibrate</td><td>The metabolism of Fenofibrate can be decreased when combined with Cobicistat.</td></tr><tr><td>Cobicistat</td><td>Rosuvastatin</td><td>Cobicistat may decrease the excretion rate of Rosuvastatin which could result in
a higher serum level.</td></tr><tr><td>Darunavir</td><td>Dolutegravir</td><td>The serum concentration of Dolutegravir can be increased when it is combined
with Darunavir.</td></tr><tr><td>Darunavir</td><td>Fenofibrate</td><td>The metabolism of Fenofibrate can be decreased when combined with Darunavir.</td></tr><tr><td>Darunavir</td><td>Metformin</td><td>The therapeutic efficacy of Metformin can be decreased when used in combination
with Darunavir.</td></tr><tr><td>Darunavir</td><td>Omeprazole</td><td>Omeprazole can cause a decrease in the absorption of Darunavir resulting in a
reduced serum concentration and potentially a decrease in efficacy.</td></tr><tr><td>Darunavir</td><td>Rosuvastatin</td><td>The serum concentration of Rosuvastatin can be increased when it is combined
with Darunavir.</td></tr><tr><td>Darunavir</td><td>Vildagliptin</td><td>The therapeutic efficacy of Vildagliptin can be decreased when used in
combination with Darunavir.</td></tr><tr><td>Dolutegravir</td><td>Cobicistat</td><td>Cobicistat may decrease the excretion rate of Dolutegravir which could result in
a higher serum level.</td></tr><tr><td>Dolutegravir</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Dolutegravir.</td></tr><tr><td>Furosemide</td><td>Fenofibrate</td><td>Furosemide may decrease the excretion rate of Fenofibrate which could result in
a higher serum level.</td></tr><tr><td>Furosemide</td><td>Rosuvastatin</td><td>The excretion of Rosuvastatin can be decreased when combined with Furosemide.</td></tr><tr><td>Furosemide</td><td>Vildagliptin</td><td>The therapeutic efficacy of Vildagliptin can be decreased when used in
combination with Furosemide.</td></tr><tr><td>Metformin</td><td>Dolutegravir</td><td>The serum concentration of Metformin can be increased when it is combined with
Dolutegravir.</td></tr><tr><td>Metformin</td><td>Furosemide</td><td>The therapeutic efficacy of Metformin can be decreased when used in combination
with Furosemide.</td></tr><tr><td>Metformin</td><td>Zofenopril</td><td>The risk or severity of lactic acidosis can be increased when Zofenopril is
combined with Metformin.</td></tr><tr><td>Omeprazole</td><td>Fenofibrate</td><td>The metabolism of Omeprazole can be decreased when combined with Fenofibrate.</td></tr><tr><td>Vildagliptin</td><td>Rosuvastatin</td><td>The therapeutic efficacy of Vildagliptin can be increased when used in
combination with Rosuvastatin.</td></tr><tr><td>Zofenopril</td><td>Furosemide</td><td>The risk or severity of renal failure and hypotension can be increased when
Furosemide is combined with Zofenopril.</td></tr><tr><td>Zofenopril</td><td>Vildagliptin</td><td>The risk or severity of angioedema can be increased when Vildagliptin is
combined with Zofenopril.</td></tr></tbody></table></div>
